Aclidinium/formoterol

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Aclidinium/formoterol
Combination of
Aclidinium bromide Long-acting muscarinic antagonist
Formoterol Long-acting β2 agonist
Clinical data
Trade names Brimica Genuair, Duaklir Genuair
AHFS/Drugs.com UK Drug Information
Routes of
administration
Inhalation
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number

Aclidinium/formoterol (trade names Duaklir and Brimica) is a combination drug for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist.[1]

References[edit]

  1. ^ "Duaklir Genuair". European Medicines Agency. 2014-12-05. Retrieved 2015-06-01.